BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Jul 17, 2023
Product Development

Momentum grows for argenx’s Vyvgart

Hits primary endpoint in Phase III ADHERE study to treat CIDP
BioCentury | Oct 25, 2010
Clinical News

Gamunex-C regulatory update

Items per page:
1 - 2 of 2